🇲🇽 Country Profile

Mexico

Fast-growing pharmaceutical trade with Mexico

🇲🇽 $450M
All data from DGCIS India export records (fiscal year, April–March).
$450M
Scale
Mexico's healthcare system receives $450M in Indian pharmaceutical products each year, affordable, quality medicine.
53%
Medicine
A diverse pharmaceutical mix: medicines, medicine ingredients, and vaccines each contributing significantly.
4.6×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Mexico has expanded 4.6× over the decade.
Context
Part of India's pharmaceutical supply network across Americas.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Mexico, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $238M (53.0%) Medicine Ingredients $97.9M (21.8%) Vaccines $87.7M (19.5%) Surgical & Hospital Supplies $17.8M (4.0%) Traditional & Herbal $8.0M (1.8%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Mexico Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Mexico: $46.2M across 51 filings (2011-2025).